Company intelligence / Profile preview

Jinling Pharmaceutical

Nanjing, Jiangsu, Chinajinling.hk ↗

Ownership: Private
Development stage: Commercial

Overview

Jinling Pharmaceutical has several commercialized drugs including Mailuoning injections/oral solutions for vascular diseases, ferrous succinate tablets for anemia, lentinan injections as an adjunct cancer therapy, absorbable gelatin sponges as medical devices for hemostasis. The company also markets the approved herbal drug Shuling Jianpi Capsule for irritable bowel syndrome. Clinical results indicate broad use in China with established safety/efficacy profiles especially in TCM-based therapies.[1][9]

Therapeutic areas: OncologyEndocrinologyHematologyRheumatologyGastroenterologyCardiovascularNeurology
Modalities: Small moleculeHerbal medicineBiologicMedical device
Industry: Biotech

Drug pipeline

3 assets

Shuling Jianpi

Unknown

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Jinling Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jinling Pharmaceutical.

Explore the full profile